Premium
Sight Sciences Inc (SGHT)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-07-06 | Mr. Jeremy B. HaydenChief Legal Officer & Corporate Secretary | -12,73k | 70,13k | Vente | 5,51 | 100,02k | -11,29% |
| 2026-07-02 | Mr. James RodbergCFO & Treasurer | -6,90k | 36,99k | Vente | 5,36 | 55,20k | -11,11% |
| 2026-07-06 | Dr. David BadawiCo-Founder, CTO & Director | -7,42k | 40,86k | Vente | 5,51 | 1,81M | -0,41% |
| 2026-07-01 | Mr. Brenton TaylorExec. VP of Operations and R&D | -2,83k | 15,33k | Vente | 5,42 | 36,70k | -7,16% |
| 2026-07-02 | Ms. Alison Perry BauerleinCOO | -24,18k | 129,63k | Vente | 5,36 | 192,67k | -11,15% |
| 2026-07-01 | Mr. Paul BadawiCo-Founder, President, CEO & Director | -28,68k | 155,47k | Vente | 5,42 | 5,57M | -0,51% |
| 2026-06-10 | Mr. Staffan E. EncrantzIndependent Chairman | 14,10k | 68,79k | Achat | 4,88 | 2,04M | 0,70% |
| 2026-05-18 | Ms. Alison Perry BauerleinCOO | -12,73k | 65,17k | Vente | 5,12 | 169,81k | -6,97% |
| 2026-04-06 | Mr. Jeremy B. HaydenChief Legal Officer & Corporate Secretary | -13,76k | 48,85k | Vente | 3,55 | 87,27k | -13,62% |
| 2026-04-06 | Mr. James RodbergCFO & Treasurer | -7,23k | 25,67k | Vente | 3,55 | 47,16k | -13,29% |
| 2026-04-02 | Dr. David BadawiCo-Founder, CTO & Director | -8,17k | 28,42k | Vente | 3,48 | 1,80M | -0,45% |
| 2026-04-02 | Ms. Alison Perry BauerleinCOO | -25,87k | 90,04k | Vente | 3,48 | 156,79k | -14,16% |
| 2026-04-01 | Mr. Brenton TaylorExec. VP of Operations and R&D | -2,87k | 10,62k | Vente | 3,70 | 31,63k | -8,32% |
| 2026-04-01 | Mr. Paul BadawiCo-Founder, President, CEO & Director | -29,24k | 108,20k | Vente | 3,70 | 5,54M | -0,52% |
| 2026-02-19 | Dr. David BadawiCo-Founder, CTO & Director | 21,27k | 4,89k | Derivative Exercise and Retained Stock | 0,23 | 1,80M | 1,20% |
| 2026-01-16 | Dr. David BadawiCo-Founder, CTO & Director | -4,84k | 32,01k | Vente | 6,62 | 1,91M | -0,25% |
| 2026-01-16 | Mr. James RodbergCFO & Treasurer | -2,62k | 17,32k | Vente | 6,62 | 151,23k | -1,70% |
| 2026-01-16 | Mr. Paul BadawiCo-Founder, President, CEO & Director | -22,36k | 148,04k | Vente | 6,62 | 5,52M | -0,40% |
| 2026-01-16 | Mr. Jeremy B. HaydenChief Legal Officer & Corporate Secretary | -6,31k | 41,76k | Vente | 6,62 | 75,56k | -7,70% |
| 2026-01-02 | Mr. Paul BadawiCo-Founder, President, CEO & Director | -37,23k | 277,18k | Vente | 7,43 - 7,48 | 5,93M | -0,62% |
| 2026-01-05 | Mr. Jeremy B. HaydenChief Legal Officer & Corporate Secretary | -11,17k | 86,74k | Vente | 7,48 - 7,82 | 245,42k | -4,35% |
| 2026-01-02 | Dr. David BadawiCo-Founder, CTO & Director | -9,66k | 73,15k | Vente | 7,43 - 7,82 | 1,92M | -0,50% |
| 2026-01-05 | Mr. James RodbergCFO & Treasurer | -5,00k | 38,89k | Vente | 7,48 - 7,82 | 153,85k | -3,15% |
| 2026-01-05 | Ms. Alison Perry BauerleinCOO | -20,54k | 157,37k | Vente | 7,48 - 7,82 | 154,15k | -11,76% |
| 2026-01-06 | Mr. Brenton TaylorExec. VP of Operations and R&D | -619,00 | 4,63k | Vente | 7,48 | 27,60k | -2,19% |
| 2025-12-26 | Dr. David BadawiCo-Founder, CTO & Director | 21,27k | 4,89k | Derivative Exercise and Retained Stock | 0,23 | 1,93M | 1,12% |
| 2022-09-21 | Dr. David BadawiCo-Founder, CTO & Director | 40,00k | 9,20k | Derivative Exercise and Retained Stock | 0,23 | 1,45M | 2,84% |
| 2025-12-16 | Mr. Staffan E. EncrantzIndependent Chairman | 13,96k | 115,96k | Achat | 8,31 | 1,99M | 0,71% |
| 2025-12-02 | Mr. James RodbergCFO & Treasurer | -2,52k | 20,77k | Vente | 8,25 | 158,85k | -1,56% |
| 2025-11-25 | Mr. Jeremy B. HaydenChief Legal Officer & Corporate Secretary | -44,85k | 274,48k | Derivative Exercise and Sale | 1,96 - 8,08 | 256,59k | - |
| 2025-11-17 | Mr. Brenton TaylorExec. VP of Operations and R&D | -14,42k | 101,79k | Vente | 7,06 | 26,61k | -35,15% |
| 2025-11-12 | Mr. Jeremy B. HaydenChief Legal Officer & Corporate Secretary | -3,15k | 19,06k | Derivative Exercise and Sale | 1,96 - 8,01 | 256,59k | - |
| 2025-10-06 | Mr. Brenton TaylorExec. VP of Operations and R&D | -591,00 | 1,99k | Vente | 3,37 | 1,02k | -36,59% |
| 2025-10-01 | Mr. Paul BadawiCo-Founder, President, CEO & Director | -24,44k | 81,63k | Vente | 3,34 | 5,96M | -0,41% |
| 2025-10-02 | Ms. Alison Perry BauerleinCOO | -19,95k | 65,83k | Vente | 3,30 | 135,62k | -12,82% |
| 2025-10-03 | Mr. Jeremy B. HaydenChief Legal Officer & Corporate Secretary | -9,73k | 31,82k | Vente | 3,27 | 256,59k | -3,65% |
| 2025-10-03 | Dr. David BadawiCo-Founder, CTO & Director | -6,03k | 19,73k | Vente | 3,27 | 1,86M | -0,32% |
| 2025-09-11 | Ms. Catherine MazzaccoIndependent Director | -37,49k | 0,00 | Other Disposition | - | 0,00 | -100,00% |
| 2025-07-17 | Dr. David BadawiCo-Founder, CTO & Director | 40,00k | 4,80k | Derivative Exercise and Retained Stock | 0,12 | 1,87M | 2,18% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
